PHD Scholarship: Anticancer Properties of Low-THC containing Medicinal Cannabis
Monday, 25 September 2017
There is an opportunity within the UON School of Biomedical Sciences and Pharmacy in the Faculty of Health and Medicine for a PhD research student to study the anticancer properties of Low-THC containing Medicinal Cannabis, under the supervision of Dr Matthew Dun and Dr Mengna Chi.
Treatments have not changed for the most common and deadly form of blood cancer, acute myeloid leukaemia (AML) in over 40 years. Unfortunately, only 24% of AML patients will live 5-years after diagnosis, highlighting the need for better therapies. Medicinal cannabis is effective for treating cancer related pain however, there is strong evidence that cannabis also has anticancer properties. In this project, we will investigate whether low THC hemp is an effective new therapeutic for AML and determine whether it is a safe complementary therapy.
$26,682 p.a. (2017 rate, indexed in January each year), for 3.5 years. The scholarship is provided by Faculty in-line with our recent successful Fellowship application.
Hon I or masters in Biomed/Sci, with a completed research project that employed drug development, biochemistry, analytical chemistry, cell culture techniques and be prepared to used animal models.
Candidate requires good English writing and comprehension skills, and be enthusiastic and hardworking.
This scholarship is open to domestic and international students.
Visit the higher degree by research scholarships website for further information about eligibility criteria (https://www.newcastle.edu.au/research-and-innovation/graduate-research/phd-and-research-degrees/scholarships).
If you are interested, please send your application to Dr Matthew Dun (Matt.Dun@newcastle.edu.au)
Contact: Dr Matthew Dun
Ph: +61 2 4921 5693